379 related articles for article (PubMed ID: 27908680)
21. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
Kaag MG; O'Malley RL; O'Malley P; Godoy G; Chen M; Smaldone MC; Hrebinko RL; Raman JD; Bochner B; Dalbagni G; Stifelman MD; Taneja SS; Huang WC
Eur Urol; 2010 Oct; 58(4):581-7. PubMed ID: 20619530
[TBL] [Abstract][Full Text] [Related]
22. Predictive ability of renal cortex enhancement in dynamic computed tomography for residual renal function after nephroureterectomy: Comparison with
Waseda Y; Saito K; Ishikawa Y; Kawano K; Yokoyama M; Ishioka J; Matsuoka Y; Morimoto S; Kihara K; Fujii Y
Int J Urol; 2019 Feb; 26(2):266-272. PubMed ID: 30368933
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
[TBL] [Abstract][Full Text] [Related]
24. Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer.
Tsao CK; Moshier E; Seng SM; Godbold J; Grossman S; Winston J; Oh WK; Galsky MD
Clin Genitourin Cancer; 2012 Mar; 10(1):15-20. PubMed ID: 22130294
[TBL] [Abstract][Full Text] [Related]
25. Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.
Hamaya T; Hatakeyama S; Tanaka T; Kubota Y; Togashi K; Hosogoe S; Fujita N; Kusaka A; Tokui N; Okamoto T; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Ohyama C
BJU Int; 2021 Oct; 128(4):468-476. PubMed ID: 33484231
[TBL] [Abstract][Full Text] [Related]
26. Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.
Lee BH; Zabor EC; Tennenbaum D; Furberg H; Benfante N; Coleman JA; Jaimes EA; Russo P
World J Urol; 2018 Feb; 36(2):257-263. PubMed ID: 29209771
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
[TBL] [Abstract][Full Text] [Related]
28. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
29. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
[TBL] [Abstract][Full Text] [Related]
31. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
[TBL] [Abstract][Full Text] [Related]
32. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract][Full Text] [Related]
33. Acute kidney injury strongly influences renal function after radical nephroureterectomy for upper tract urothelial carcinoma: A single-centre experience.
Tafuri A; Odorizzi K; Di Filippo G; Cerrato C; Fassio G; Serafin E; Princiotta A; D'Aietti D; Gozzo A; Porcaro AB; Brunelli M; Cerruto MA; Antonelli A
Arch Ital Urol Androl; 2021 Mar; 93(1):9-14. PubMed ID: 33754601
[TBL] [Abstract][Full Text] [Related]
34. Segmental ureterectomy vs. radical nephroureterectomy for ureteral carcinoma in patients with a preoperative glomerular filtration rate less than 90 ml/min/1.73 m
Abrate A; Sessa F; Campi R; Preto M; Olivero A; Varca V; Benelli A; Sessa M; Sebastianelli A; Pavone C; Serretta V; Vella M; Brunocilla E; Serni S; Trombetta C; Terrone C; Gregori A; Lissiani A; Gontero P; Schiavina R; Gacci M; Simonato A
Urol Oncol; 2020 Jun; 38(6):601.e11-601.e16. PubMed ID: 32273050
[TBL] [Abstract][Full Text] [Related]
35. A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Necchi A; Martini A; Raggi D; Cucchiara V; Colecchia M; Lucianò R; Villa L; Mazzone E; Basile G; Scuderi S; Pederzoli F; Bandini M; Barletta F; Larcher A; Capitanio U; Salonia A; Briganti A; Ross JS; Messina A; Montorsi F
Urol Oncol; 2022 Jan; 40(1):10.e1-10.e6. PubMed ID: 34147313
[TBL] [Abstract][Full Text] [Related]
36. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
[TBL] [Abstract][Full Text] [Related]
37. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
[TBL] [Abstract][Full Text] [Related]
38. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
39. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
[TBL] [Abstract][Full Text] [Related]
40. The Remaining Ipsilateral Ureteral Orifice Provokes Intravesical Tumor Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Study With a Mid-Term Follow-Up.
Kwon SY; Ko YH; Song PH; Kim BH; Kim BS; Kim TH;
Urology; 2020 Nov; 145():166-171. PubMed ID: 32791287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]